NHBE cells infected with SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
ENSG00000006468.9 | ETS variant transcription factor 1 | |
ENSG00000105722.5 | ETS2 repressor factor | |
ENSG00000163497.2 | FEV transcription factor, ETS family member | |
ENSG00000120690.9 | E74 like ETS transcription factor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ERF | hg19_v2_chr19_-_42759300_42759324 | -0.81 | 5.2e-02 | Click! |
ELF1 | hg19_v2_chr13_-_41593425_41593480 | -0.57 | 2.4e-01 | Click! |
ETV1 | hg19_v2_chr7_-_14028488_14028516 | -0.55 | 2.6e-01 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 7.0 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
0.1 | 6.6 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 5.4 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.0 | 4.3 | GO:0006415 | translational termination(GO:0006415) |
0.7 | 4.0 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 3.9 | GO:1901998 | toxin transport(GO:1901998) |
0.3 | 3.8 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.1 | 3.8 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.0 | 3.7 | GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) |
0.0 | 3.6 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 7.8 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.6 | 6.9 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 6.9 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 6.6 | GO:0002102 | podosome(GO:0002102) |
0.2 | 6.4 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 6.3 | GO:0030118 | clathrin coat(GO:0030118) |
0.0 | 5.5 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.2 | 4.8 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 4.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 4.4 | GO:0022626 | cytosolic ribosome(GO:0022626) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 7.0 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 6.0 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 4.8 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 4.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 3.9 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 3.2 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.5 | 2.9 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.1 | 2.8 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.9 | 2.6 | GO:0035539 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
0.5 | 2.6 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 3.4 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 3.2 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 2.6 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 2.1 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 1.9 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 1.6 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 1.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 1.3 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 1.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 1.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 7.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 6.2 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 5.0 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.1 | 4.9 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 3.8 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 3.8 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.0 | 3.7 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 3.6 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 3.4 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 3.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |